Sulfonyl amide derivatives for the treatment of abnormal cell growth
AU2014240252A1
Anti-CTLA-4 Antibody Compositions
AU2014201847A1
Sulfonyl amide derivatives for the treatment of abnormal cell growth
JP2013231185A
Hard hydroxypropylmethyl cellulose capsule and manufacturing method
AU2013201732A1
Methods of vaccine administration
ZA201001164B
Polymorphs of 3-((4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino)-methyl)-phenoxy)-acetic acid sodium salt or a hydrate thereof and methods for making the same
ZA200906990B
Crystalline forms of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-E-[2-(pyridin-2-yl) ethenyl] indazole suitable for the treatment of abnormal cell growth in mammals
WO2009063367A1
Dosage forms comprising celecoxib providing both rapid and sustained pain relief
WO2009056934A1
1,4-dihydronaphthyridine derivatives
AU2008315718A1
Idarubicin for the treatment of lymphoma in a dog
WO2009050646A2
Multi-compartmented container
TW200918509A
Pharmaceutical compounds and derivatives
US2011046385A1
Polymorphs Of Prostaglandin Agonists And Methods For Making The Same
AU2008291814A1
Polymorphs of 3- ( ( (4-tert-butyl-benzyl) - (pyridine-3-sulfonyl) -amino) -methyl) -phenoxy) -acetic acid sodium salt or a hydrate thereof and methods for making the same
WO2009027803A2
Polymorphs of (3-(((4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino)-methyl)- phenoxy)-acetic acid, free acid
CA2695357A1
Process for preparing chiral compounds
RS51690B
Substituted bicyclolactam compounds
WO2009001214A2
Thieno[2,3-d]pyrimidin-4(3h)-one, isoxazolo[5,4-d]pyrimidin-4(5h)-one and isothiazolo[5,4-d]pyrimidin-4(5h)-one derivatives as calcium receptor antagonists
WO2008135855A2
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
WO2008135829A2
Nanoparticles comprising cox-2 inhibitors and a non-ionizable polymer
